Clinical Trial Update: AeriSeal System for Lung Volume Reduction [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of Phase 1 and Phase 2 trials evaluating the AeriSeal System for lung volume reduction in emphysema and COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Emphysema

Drugs mentioned

• AeriSeal System

Snippet

Sponsor: Aeris Therapeutics | Conditions: Emphysema, Chronic Obstructive Pulmonary Disease (COPD) | Phase 1, Phase 2 | Status: COMPLETED